• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Pay 2023 Membership Dues
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Play Eczema Counts Now!
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • SPD/PeDRA Journal Club
        • PeDRA Podcasts
        • Points of Discussion Podcast
        • Mentorship Program
        • 2023 Annual Conference
        • Dash for Discovery Fun Run/Walk
        • Early Investigator Support
        • Play Eczema Counts Now!
        • Events Calendar
        • Save the Date! The 2023 PeDRA Annual Conference will be held November 9-11, 2023 at the Westin Buckhead Atlanta in Atlanta, GA.

           

           

          Explore our new educational catalog!

  • Research
        • Grants and Fellowships
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • Now accepting applications for the Emerging Investigator Research Grants Program.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports & Financials
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • 2022 marked PeDRA’s 10th year of pursuing the vision of changing lives and healing children with skin disease through collaboration and discovery. Visit our 10th Anniversary Page to learn more about the origin of PeDRA and the many accomplishments during the first ten years!

  • Member Login

Effects of IBAT inhibitors on itch in pediatric liver disease patients

June 6, 2022 By Katherine Devenport


Fellow

Siri Choragudi
University of Miami Miller School of Medicine

Mentor

Gil Yosipovitch, MD
University of Miami Miller School of Medicine

Overview

A common and often unbearable side effect of cholestatic genetic liver disease is that patients experience uncontrollable itch due to increased levels of bile acids in the bloodstream. This side effect is especially difficult for children to deal with, as they may have limited understanding of their conditions and little experience coping with significant physical discomfort. IBAT inhibitors, drugs that can reduce bile acids and therefore itchiness, were recently approved by the FDA for use in children. However, little is known about the efficacy of these drugs in this population. This research study aims to fill this gap in knowledge and improve treatment by using an in-depth Itch Severity, Quality of Life and Well Being surveys to assess 30-40 pediatric liver transplant patients’ experiences before and after IBAT inhibitor use.

Status

This project was funded through a 2022 PeDRA Research Fellowship Grant.

Filed Under: Cross-cutting Research

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Governance Policies
  • Financial Conflict of Interest Policy
  • Jobs at PeDRA
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2023 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy